Rubicon Research

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
784.50
-4.05 (-0.51%)
BSENSE

Feb 06

BSE+NSE Vol: 1.52 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Net Sales
1,240.04
926.13
Other Operating Income
0.00
0.00
Total Operating income
1,240.04
926.13
Raw Material Cost
459.92
330.67
Purchase of Finished goods
46.37
63.49
(Increase) / Decrease In Stocks
-119.54
-130.37
Employee Cost
187.93
154.52
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
Other Expenses
383.84
316.02
Total Expenditure (Excl Depreciation)
958.52
734.34
Operating Profit (PBDIT) excl Other Income
281.52
191.79
Other Income
5.12
3.53
Operating Profit (PBDIT)
286.64
195.32
Interest
31.80
24.93
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
254.84
170.39
Depreciation
32.99
26.93
Profit Before Tax
221.85
143.46
Tax
51.90
45.35
Provisions and contingencies
0.00
0.00
Profit After Tax
169.95
98.11
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
169.95
98.11
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
169.95
98.11
Equity Capital
16.48
15.21
Face Value
1.0
1.0
Reserves
0.00
0.00
Diluted Earnings per share
4.41
2.46
Operating Profit Margin (Excl OI)
22.7%
20.71%
Gross Profit Margin
20.55%
18.4%
PAT Margin
13.71%
10.59%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 18.52%

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -7.17%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is -1.97%

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 8.76%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Rubicon Research With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,240.04
993.37
246.67
24.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,240.04
993.37
246.67
24.83%
Raw Material Cost
459.92
294.64
165.28
56.10%
Purchase of Finished goods
46.37
0.00
46.37
(Increase) / Decrease In Stocks
-119.54
6.14
-125.68
-2,046.91%
Employee Cost
187.93
185.45
2.48
1.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
383.84
294.84
89.00
30.19%
Total Expenditure (Excl Depreciation)
958.52
781.07
177.45
22.72%
Operating Profit (PBDIT) excl Other Income
281.52
212.30
69.22
32.60%
Other Income
5.12
12.93
-7.81
-60.40%
Operating Profit (PBDIT)
286.64
225.23
61.41
27.27%
Interest
31.80
99.67
-67.87
-68.09%
Exceptional Items
0.00
-9.96
9.96
100.00%
Gross Profit (PBDT)
254.84
115.60
139.24
120.45%
Depreciation
32.99
207.27
-174.28
-84.08%
Profit Before Tax
221.85
-91.67
313.52
342.01%
Tax
51.90
-13.27
65.17
491.11%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
169.95
-78.40
248.35
316.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
169.95
-78.40
248.35
316.77%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
169.95
-78.40
248.35
316.77%
Equity Capital
16.48
11.46
5.02
43.80%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
20.55%
11.64%
0.00
8.91%
PAT Margin
13.71%
-7.89%
0.00
21.60%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 916.20 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 118.14 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 204.48 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Interest
Interest 25.57 Cr
in Dec 2025

Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.32%
in Dec 2025

Figures in %